AccuBreath Inc Information

AccuBreath has developed an ultraportable ventilator intended to replace manual resuscitators, which are widely used but contribute to a significant number of acute lung injury (ALI) cases due to the risk of over-ventilation. In the U.S., outdated bag-valve mask devices are associated with approximately 190,600 ALI cases and 75,000 related deaths annually, creating an estimated economic burden of $20.4 billion. AccuBreath’s device is designed to deliver controlled ventilation that adapts to patient needs, provide precise monitoring, and support spontaneous breathing. It also includes modes such as CPAP and BiPAP for transport, enabling broader use beyond basic resuscitation. The company targets first responders as primary users, with fire departments and ambulatory facilities serving as purchasing entities.